Q
Search for a condition, service or location
Translate this page

Covid 19 Information

Please visit www.ghc.nhs.uk/coronavirus/

Performance in Initiating and Delivering Clinical Research

The Government wishes to see a dramatic and sustained improvement in the performance of providers of NHS services in initiating and delivering clinical research. The aim is to increase the number of patients who have the opportunity to participate in research and to enhance the nation’s attractiveness as a host for research.

As part of the oversight of this aim, providers of NHS Services are required to publish information on recruitment to clinical trials and delivery to time and to target for commercial clinical trials.

Until the COVID-19 Outbreak, performance reports were uploaded on a quarterly basis but the pandemic meant reporting was suspended from Quarter 3 of 2019/20 until Q2 of 2020/21.

Reporting has started up again now and the link below will take you to the last 4 quarterly reports for Gloucestershire Health and Care NHS Foundation Trust.

https://ccfctp.nihr.ac.uk/public-trustsubmissions/gloucestershire-health-and-care-nhs-foundation-trust-1104

The reports include two tables for each quarter:

Performance in Initiating Clinical Research

This report provides information about studies with a DATE SITE SELECTED that falls within the last 12 months. This applies to only Clinical Trials approved through the HRA systems. Clinical Trials approved under the old systems are now excluded. The table identifies where delays in set-up and recruitment of first patients have occurred, providing transparency of process. Where Sponsor expectations have not been met by the Trust, this information is recorded. In the table

Performance in Delivering Clinical Research

This report provides information about Commercially Sponsored research hosted by Gloucestershire Health and Care NHS Foundation Trust in relation to meeting the Time and Target metric (HLO#2) and includes those studies that have closed in the last 12 months.

Where tables are empty, the Trust as reported a “NIL RETURN” for that quarter, meaning that no new Clinical Trials were opened or no Commercially-Sponsored Clinical Trials closed during that period.

If there are any questions about these reports or the benchmarks themselves, please contact Mark Walker, Head of Research and Development on 01242 634491 or mark.walker@ghc.nhs.uk

Accessibility